Title
Category
Credits
Event date
Cost
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.
  • Antipsychotics
  • Movement Disorders
  • Neurology
  • Patient/Physician Communication
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
  • Antipsychotics
  • Diagnostic Tools
  • Movement Disorders
  • Patient/Physician Communication
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Although clinicians are pressed for time, diligence in assessing for tardive dyskinesia in patients taking antipsychotics is crucial, especially now that treatment is available. In this brief CME activity, Dr Nierenberg describes the evaluation process. 
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the cardinal features of Parkinson disease? What other motor and nonmotor symptoms do patients experience? Review diagnosis and assessment tools.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Which medications can improve the motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges.
  • Antipsychotics
  • Functional Impairment
  • Movement Disorders
  • Neurology
  • Side Effects
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Learn more from Dr. Joseph McEvoy.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy “wears off.” How can you increase their ON time? In this CME activity, follow along as 2 experts review evidence on treatment.
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In this CME activity, listen to a panel of MDD experts discuss best practices and novel antidepressants at the 2019 ASCP Annual Meeting.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Finally, you can offer patients with tardive dyskinesia approved medications that reduce symptoms. In this CME, Dr Leslie Citrome reviews the evidence.
  • Antipsychotics
  • Mood Disorders
  • Movement Disorders
  • Neurology
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Review highlights from two experts’ presentations on identifying and treating tardive dyskinesia. Quotes from actual patients illustrate the embarrassment that they feel and show why even mild movements should be treated if patients are distressed by them.

Pages